BioWorld MedTech

Oct. 26, 2011

Accuray gains approval for TomoTherapy DCS component

Accuray (Sunnyvale, California) reported that FDA has granted it 510(k) clearance to market its Dose Control System (DCS), a new feature for Accuray's TomoTherapy device that is said to improve system performance. Read More

French Radiology Congress: The dark horse in PACS, can France take the lead?

Report from Europe: Epigenomics launches Epi proColon 2.0 CE in Europe

Washington roundup: MDT has good efficacy, iffy safety data for Frontiers PMA

Agreements/contracts: Foundation reports collaboration on cancer genomic test with J&JPRD

Financings roundup: EGHC gains new investors to help boost funding drive

Clarification

Court report: DaVita to receive inquiry from HHS on dialysis drug payments

People in the News

Grants roundup: NERI wins $45 million grant for Pediatric Heart Network

Patent roundup: Daxcor reports filing for albumin measurement instrument patent

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...